Q3136510 (Q3136510): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
(‎Created claim: summary (P836): Objective: Establish and integrate inflammatory and immunological parameters, endothelial damage and vascular pathology related to accelerated senescence in patients with advanced chronic kidney disease (ACD). Variation of these parameters depending on the different dialysis and transplant treatments. Methodology: Prospective Study in Incident Patients with Advanced Chronic Kidney Disease from the Nephrology Service of Hospital Twelve in Octob...)
Property / summary
 
Objective: Establish and integrate inflammatory and immunological parameters, endothelial damage and vascular pathology related to accelerated senescence in patients with advanced chronic kidney disease (ACD). Variation of these parameters depending on the different dialysis and transplant treatments. Methodology: Prospective Study in Incident Patients with Advanced Chronic Kidney Disease from the Nephrology Service of Hospital Twelve in October Madrid. The state of fragility and REDOX status of patients, subpopulations of immune cells (senescence and function), immunological factors and endothelial and vascular damage will be quantified. Determinations will be made in patients with RAC (Phase1), when they enter dialysis programs (Phase 2) and then transplant (Phase 3), and every six months while in the same phase. A risk score for cardiovascular morbidity and mortality shall be established based on the parameters obtained. (English)
Property / summary: Objective: Establish and integrate inflammatory and immunological parameters, endothelial damage and vascular pathology related to accelerated senescence in patients with advanced chronic kidney disease (ACD). Variation of these parameters depending on the different dialysis and transplant treatments. Methodology: Prospective Study in Incident Patients with Advanced Chronic Kidney Disease from the Nephrology Service of Hospital Twelve in October Madrid. The state of fragility and REDOX status of patients, subpopulations of immune cells (senescence and function), immunological factors and endothelial and vascular damage will be quantified. Determinations will be made in patients with RAC (Phase1), when they enter dialysis programs (Phase 2) and then transplant (Phase 3), and every six months while in the same phase. A risk score for cardiovascular morbidity and mortality shall be established based on the parameters obtained. (English) / rank
 
Normal rank
Property / summary: Objective: Establish and integrate inflammatory and immunological parameters, endothelial damage and vascular pathology related to accelerated senescence in patients with advanced chronic kidney disease (ACD). Variation of these parameters depending on the different dialysis and transplant treatments. Methodology: Prospective Study in Incident Patients with Advanced Chronic Kidney Disease from the Nephrology Service of Hospital Twelve in October Madrid. The state of fragility and REDOX status of patients, subpopulations of immune cells (senescence and function), immunological factors and endothelial and vascular damage will be quantified. Determinations will be made in patients with RAC (Phase1), when they enter dialysis programs (Phase 2) and then transplant (Phase 3), and every six months while in the same phase. A risk score for cardiovascular morbidity and mortality shall be established based on the parameters obtained. (English) / qualifier
 
point in time: 12 October 2021
Timestamp+2021-10-12T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 13:28, 12 October 2021

Project Q3136510 in Spain
Language Label Description Also known as
English
No label defined
Project Q3136510 in Spain

    Statements

    0 references
    0 references
    46,000.0 Euro
    0 references
    92,000.0 Euro
    0 references
    50.0 percent
    0 references
    1 January 2018
    0 references
    31 March 2021
    0 references
    FUNDACION INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
    0 references
    0 references

    40°25'0.12"N, 3°42'12.89"W
    0 references
    28079
    0 references
    Objetivo: Establecer e integrar parámetros inflamatorios e inmunológicos, de daño endotelial y de patología vascular relacionados con la senescencia acelerada en pacientes con enfermedad renal crónica avanzada (ERCA). Variación de estos parámetros en función de los diferentes tratamientos de diálisis y trasplante. Metodología: Estudio prospectivo en pacientes incidentes con enfermedad renal crónica avanzada del Servicio de Nefrología del Hospital Doce de Octubre de Madrid. Se cuantificará el estado de fragilidad y situación REDOX de los pacientes, subpoblaciones de células inmunes (senescencia y función), factores inmunológicos y de daño endotelial y vascular. Las determinaciones se realizarán en los pacientes con ERCA (Fase1) ,cuando entran en programas de diálisis (Fase 2) y posteriormente en trasplante (Fase 3), y cada seis meses mientras permanezcan en la misma fase. Se establecerá un score de riesgo de morbimortalidad cardiovascular en función de los parámetros obtenidos. (Spanish)
    0 references
    Objective: Establish and integrate inflammatory and immunological parameters, endothelial damage and vascular pathology related to accelerated senescence in patients with advanced chronic kidney disease (ACD). Variation of these parameters depending on the different dialysis and transplant treatments. Methodology: Prospective Study in Incident Patients with Advanced Chronic Kidney Disease from the Nephrology Service of Hospital Twelve in October Madrid. The state of fragility and REDOX status of patients, subpopulations of immune cells (senescence and function), immunological factors and endothelial and vascular damage will be quantified. Determinations will be made in patients with RAC (Phase1), when they enter dialysis programs (Phase 2) and then transplant (Phase 3), and every six months while in the same phase. A risk score for cardiovascular morbidity and mortality shall be established based on the parameters obtained. (English)
    12 October 2021
    0 references
    Madrid
    0 references

    Identifiers

    PI17_01029
    0 references